Xocova Priced at 51,851 Yen per Course with Peak Sales Put at 19.2 Billion Yen

Chuikyo General Assembly Meeting on March 8 An all-important Japanese reimbursement policy panel on March 8 approved the NHI price listing of Shionogi’s COVID-19 pill Xocova (ensitrelvir) at 51,851 yen per course of treatment, with peak sales projected at 19.2...read more